发明公开
- 专利标题: HEMATOLOGICAL ASSAY AND REAGENT
- 专利标题(中): 血液测定与试药
-
申请号: EP00991194.2申请日: 2000-12-14
-
公开(公告)号: EP1240528A2公开(公告)日: 2002-09-18
- 发明人: GEMPELER, Patrizia, Maria , CALATZIS, Andreas
- 申请人: Pentapharm AG
- 申请人地址: Engelgasse 109 4052 Basel CH
- 专利权人: Pentapharm AG
- 当前专利权人: Pentapharm AG
- 当前专利权人地址: Engelgasse 109 4052 Basel CH
- 代理机构: Braun, André
- 优先权: PCT/EP99/09952 19991215
- 国际公布: WO01044819 20010621
- 主分类号: G01N33/86
- IPC分类号: G01N33/86 ; C12Q1/56
摘要:
A hematological assay is described in which the blood coagulation potential of a body fluid is assessed by reacting a sample of the body fluid with an amount of an activator reagent comprising: (a) a predetermined amount of factor Xa or a hematologically equivalent mutant thereof, and (b) a predetermined amount of factor Va, a hematologically equivalent mutant thereof or an enzyme activating endogenous factor V, (c) (optionally) phospholipids. The reagent may be dry (e.g. lyophilised) or in an aqueous solution preferably buffered to a pH from 6 to 10 (preferably 7 to 8), if desired incubating, if necessary inducing coagulation by the addition of one or more coagulation accelerants such as calcium chloride, and establishing a value indicative of the coagulation potential, e.g. by measuring the time to clotting on an optical coagulometer or through use of a chromogenic substrate. It is preferred to use at (b) factor V activator from purified Russell's Viper venom (RVV-V). An activator reagent is also described containing the components mentioned above preferably in one or more buffer solutions or in dried, e.g. lyophilised form.
公开/授权文献
- EP1240528B1 HEMATOLOGICAL ASSAY AND REAGENT 公开/授权日:2005-12-07
信息查询
IPC分类: